---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-002103"
form_type: "8-K"
ticker: "RCKT"
cik: "0001281895"
company_name: "ROCKET PHARMACEUTICALS, INC."
filed_at: "2025-01-28T23:59:59+00:00"
generated_at: "2026-05-27T08:02:56.833438+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Rocket Pharmaceuticals appoints Piratip Pratumsuwan to Board; Yalamanchi resigns

## Summary
- Naveen Yalamanchi resigned from Board effective Jan 25, 2025; no disagreement.
- Piratip Pratumsuwan appointed to Board effective Jan 27, 2025.
- Pratumsuwan is Managing Director, Research Analyst at RTW Investments, specializing in gene therapy.
- Received option grants: $360k (3-year monthly vest) and $155k (1-year cliff vest).
- Age 33; M.A. in Biotechnology from Columbia, B.S. in Biochemistry from McGill.

## SEC filing metadata
- accession: 0001140361-25-002103
- form_type: 8-K
- ticker: RCKT
- cik: 0001281895
- company_name: ROCKET PHARMACEUTICALS, INC.
- filed_at: 2025-01-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1281895/000114036125002103/0001140361-25-002103-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1281895/000114036125002103/ef20042399_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-002103
- JSON: https://secwatch.observer/filing/0001140361-25-002103.json
- Plain text: https://secwatch.observer/filing/0001140361-25-002103.txt

## Key facts
- Executive change
  Piratip Pratumsuwan was appointed as Director at ROCKET PHARMACEUTICALS, INC..
  - Action: appointed
  - Role: Director
  source text: On January 25, 2025, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Piratip Pratumsuwan to the Board, effective January 27, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1281895/000114036125002103/0001140361-25-002103-index.htm
- Executive change
  Naveen Yalamanchi resigned as Director at ROCKET PHARMACEUTICALS, INC..
  - Action: resigned
  - Role: Director
  source text: On January 25, 2025, Naveen Yalamanchi resigned from the Board of Directors (the “Board”) of Rocket Pharmaceuticals, Inc. (the “Company”), effectively immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1281895/000114036125002103/0001140361-25-002103-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.